Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Medivir Hep C Drug Cures 80 Percent of Patients Post-Treatment
Medivir’s experimental hepatitis C treatment TMC435 cured as many as 80 percent of patients 24 weeks after treatment ended, suggesting that the therapy prevents the virus from surging back.
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing